At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 101 enrolled
Drug / intervention
Vitamin D3 +2 moredrug
Likely dose
Vitamin D3 10,000 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effects of Vitamin D on Balance in Persons With PD
In Brief
A Phase 2 clinical trial evaluating Vitamin D3, calcium, and 1 other intervention for Parkinson Disease and Accidental Falls. Completed, enrolled 101 participants across 1 site.
Detailed Summary
A trial to measure the effects of vitamin D (versus a placebo) on balance, gait, falls, strength, and cognition in persons with Parkinson's disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease, Accidental Falls
CountriesUnited States
CollaboratorsOregon Health and Science University
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 2010
Enrollment StartMay 2011
Primary CompletionJan 2015
TodayJul 2026
First PostedMay 7, 2010
Enrollment StartMay 1, 2011
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 16.2 years ago
Interventions
Vitamin D3drug
Vitamin D3 at 10,000 IU a day
calciumdietary
1000mg calcium daily
Placeboother
A placebo pill with similar appearance to the vitamin D3 will be given to those in the placebo arm